This guideline covers diagnosing and managing non-small-cell and small-cell lung cancer. It aims to improve outcomes for patients by ensuring that the most effective tests and treatments are used, and that people have access to suitable palliative care and follow-up. ...
Presents information on guidelines for the diagnosis and treatment of lung cancer issued by the National Institute for Clinical Excellence in Great Britain. Use of gemcitabine, paclitaxel, docetaxel and vinorelbine for the treatment of non-small-cell lung cancer; Recommendations for utilization of early...
The aim of this study is to analyse the trends in technology appraisals for non-small cell lung cancer (NSCLC) treatments performed by the National Institute for Health and Care Excellence (NICE) over the last ten years.A systematic search was conducted for single technology appraisals of NSCLC...
A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer Our aim was to evaluate the clinical effectiveness of chemotherapy treatments currently licensed in Europe and recommended by the National Institute...
SEER data show that small cell lung cancer (SCLS) incidence has steadily declined due to reduced smoking rates, but survival outcomes have seen only minimal improvement, underscoring the need for more effective treatments. February 8th 2025 Hospitalization Patterns Among Older Patients With Cancer With...
It said the treatment should be made available on England's Cancer Drugs Fund (CDF) for patients with untreated, metastatic, non-squamous non-small-cell lung cancer in adults whose tumours have no epidermal growth factor receptor (EGFR)- or anaplastic lymphoma kinase (ALK)-positive mutations. ...
The article presents the guidelines for the treatment of psoriasis in adults, non-small-cell lung cancer (NSCLC) and gastrointestinal stromal tumours (GISTs) from Great Britain National Institute for Health and Clinical Excellence (NICE). The use of ustekinumab is recommended if the person has ...
Summary: Between January 1, 1991 until December 31, 1996, 286 patients with non-small cell lung cancer were diagnosed and treated in the Department of Tube... J Skrickova,S Spelda,J Kaplanova - 《Acta Medica Austriaca》 被引量: 0发表: 2010年 ...
The article presents the guidelines for the treatment of psoriasis in adults, non-small-cell lung cancer (NSCLC) and gastrointestinal stromal tumours (GISTs) from Great Britain National Institute for Health and Clinical Excellence (NICE). The use of ustekinumab is recommended if the person has ...
Bernice Dillon,Bhash Naidoo,Helen Knight,Peter Clark.NICE guidance on erlotinib for first-line treatment of EGFR-TK mutation-positive advanced or metastatic non-small-cell lung cancer[J]. Lancet Oncology .2012(8)Dillon B;Naidoo B;Knight H;.NICE guidance on erlotinib for first-line treatment ...